Unit of Clinical Pharmacology Department of Biomedical and Clinical Sciences L. Sacco, "Luigi Sacco" University Hospital, Università di Milano, 20157, Milan, Italy.
Department of Diagnostics and Public Health, Section of Pharmacology, University of Verona, Verona, Italy.
Eur J Pediatr. 2019 Feb;178(2):161-172. doi: 10.1007/s00431-018-3281-0. Epub 2018 Oct 29.
Recent epidemiological studies have reported an increase in central nervous system (CNS)-active drug abuse rates in paediatric settings, raising several public health concerns. No study to date has explored this issue worldwide. We performed an extensive analysis of drugs abuse/overdose reported for children in the last decade by using the largest pharmacovigilance database, i.e. the VigiBase, collecting adverse drug reaction reports that involved at least one suspect drug belonging to the Anatomical Therapeutic Chemical code "Nervous System" through the Standardised Medical Dictionary for Drug Regulatory Affairs Queries for Drug abuse. 8.682 reports matched our criteria. An increase in reporting activity was observed, starting from 2014; an intentional overdose was reported more frequently than an accidental one, with a difference between age groups. We retrieved 997 reports with death outcome. These referred more to adolescents (n = 538) than subjects of any other paediatric age group. Paracetamol and opioid analgesics were the most common suspect drugs in deaths across all age groups due to hypoxic-ischaemic encephalopathy, brain death, and cardio-respiratory arrest.Conclusion: The number of reports associated with drug abuse and overdose is increasing (for opioid and paracetamol-containing products) and a considerable number of adverse drug reactions are serious. Data on the patterns of use of such medicines from each country may help in implementing strategies of risk-minimisation and renewing healthcare recommendations worldwide. An increased clinical awareness of drug abuse and overdose is warranted, while continuing to provide effective treatments. What is Known: • The large increase in paediatric prescriptions for CNS-active drugs in the last 20 years has recently raised public health concerns about drug abuse and overdose. • No study to date has examined this issue in paediatric patients worldwide. What is New: • The number of paediatric reports associated with CNS drug abuse and intentional overdose is increasing, including those with fatal outcome; over 4 years; more than 35% of the reports was entered from European countries. • Opioid and paracetamol were most frequently suspected for ADRs with fatal outcome across all age groups, due to hypoxic-ischaemic encephalopathy and cardio-respiratory arrest, suggesting the need to implement strategies of risk-minimisation.
最近的流行病学研究报告称,儿科环境中中枢神经系统(CNS)活性药物滥用率有所上升,引发了一些公共卫生关注。迄今为止,尚无研究在全球范围内探讨这一问题。我们使用最大的药物警戒数据库(即 VigiBase)对过去十年中儿童报告的药物滥用/过量情况进行了广泛分析,通过药物滥用标准医学词典查询,收集了至少涉及一种属于解剖治疗化学代码“神经系统”的可疑药物的不良药物反应报告。符合我们标准的报告有 8682 份。从 2014 年开始,报告活动有所增加;故意过量报告比意外过量报告更为频繁,不同年龄组之间存在差异。我们检索到 997 份有死亡结果的报告。这些报告更多涉及青少年(n=538),而不是任何其他儿科年龄组的患者。在所有年龄组中,由于缺氧缺血性脑病、脑死亡和心肺骤停,对乙酰氨基酚和阿片类镇痛药是导致死亡的最常见可疑药物。结论:与药物滥用和过量相关的报告数量正在增加(阿片类药物和含对乙酰氨基酚的产品),并且相当数量的药物不良反应是严重的。来自每个国家的此类药物使用模式的数据可能有助于在全球范围内实施风险最小化策略和更新医疗保健建议。需要提高对药物滥用和过量的临床认识,同时继续提供有效的治疗方法。已知:• 过去 20 年来,儿童中枢神经系统活性药物的大量处方增加,最近引起了人们对药物滥用和过量的公共卫生关注。• 迄今为止,尚无研究在全球儿科患者中检查过这个问题。新内容:• 与中枢神经系统药物滥用和故意过量相关的儿科报告数量正在增加,包括有致命结果的报告;在超过 4 年的时间里;超过 35%的报告来自欧洲国家。• 阿片类药物和对乙酰氨基酚在所有年龄组中最常被怀疑与 ADR 有关,导致缺氧缺血性脑病和心肺骤停,这表明需要实施风险最小化策略。